Shares of Acadia Pharmaceuticals ACAD lost 9.9% on Wednesday after the company announced a disappointing update from a late-stage study of its investigational candidate, intranasal carbetocin (ACP-101 ...

Acadia Pharmaceuticals ACAD announced that it has signed an exclusive worldwide license agreement with Saniona, a Denmark-based clinical-stage biopharmaceutical company, to develop and commercialize ...

Acadia Pharmaceuticals (ACAD) closed the last trading session at $22.99, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...

We recently published a list of 10 Firms End 2024 Stronger With Impressive Gains. In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other ...

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) stock jumped 26.6% to $22.29 on Friday afternoon following a favorable court ruling. What To Know: The U.S. District Court for the District of Delaware upheld ...

In trading on Thursday, shares of Acadia Pharmaceuticals Inc (Symbol: ACAD) crossed above their 200 day moving average of $16.68, changing hands as high as $16.82 per share. Acadia Pharmaceuticals Inc ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

A high-level overview of ACADIA Pharmaceuticals Inc. (ACAD) stock. View (ACAD) real-time stock price, chart, news, analysis, analyst reviews and more.